Lexeo Therapeutics, Inc. (LXEO) › EPS (Diluted)Lexeo Therapeutics, Inc. (LXEO) — EPS (Diluted)Annual figures by period end, from SEC filings.2022-12-31: $-36.362023-12-31: $-12.402024-12-31: $-3.092025-12-31: $-1.86$-1.862022-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-1.86—2026-03-30From 2025-01-012024-12-31$-3.09—2026-03-30From 2024-01-012023-12-31$-12.40—2025-03-24From 2023-01-012022-12-31$-36.36—2024-03-11From 2022-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)